|
Recent Developments |
|
16-JUN-14
Arvind Remedies announced today that the company signed memorandum of understanding (MoU) with Adesh University, Punjab, to transfer the patent right to the company for manufacturing and marketing of formulation product from botanical source for treatment of Type 2, diabetes, coronary heart disease, neuro and anti depression.
28-MAY-14
Arvind Remedies announced that the company has signed Memorandum of Understanding (MoU) with SRM Un... More.. |
| Business Profile |
Future Plans |
|
| CEO Talk | | Arvind Remedies expects its turnover to grow 20-30 per cent in the current fiscal, while net profit is likely to jump substantially. The company`s herbal division is expected to register a 40 per cent growth in turnover during the next three years, while allopathic division will grow 15 per cent. Arvind Shah |
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2014(9) | 31-Mar-2014 (12) | 31-Mar-2013 (12) | | Net sales | 7276.53 | 9104.86 | 6632.60 | | Other Income | 13.50 | 4.65 | 5.93 | | Total Income | 7290.03 | 9109.51 | 6638.53 | | Cost of goods sold | 6439.40 | 7341.69 | 5305.28 | | OPBDIT | 850.63 | 1767.82 | 1333.25 | | PAT | -1305.61 | 588.99 | 406.17 | | Gross Block | - | - | - | | Equity capital | 681.26 | 681.26 | 482.30 | | EPS (Rs.) | - | 10.02 | 8.42 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 2.64 - 5.98 | 0.26 - 4.76 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 11.7 | 19.4 | 20.1 | | Net margin (% of OI) | -17.9 | 6.5 | 6.1 |
|
|
Detailed Financials
|
|
|
|
|
